Web Analytics

3 Latest Announced Rounds

  • $43,000,000
    Series B

    1 Investors

    Hospital & Health Care
    Nov 14th, 2025
  • $3,500,000
    Seed
    IT Services and IT Consulting
    Nov 14th, 2025
  • Undisclosed Amount
    Series A

    1 Investors

    Software Development
    Nov 14th, 2025
$917.70M Raised in 40 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Phialogics - The immune tolerance company

start up
Germany - Frankfurt, Hesse
  • 08/05/2023
  • Pre-Seed
  • $662,970

Our immune checkpoint activators protect patient’s organ tissue.
Unique approach :
- Potential for BEST-in-class super agonist against immune-mediated tissue damage
- High selectivity for active T-cells
- Proof of concept in relevant human in vitro models and mouse model of disease


Related People

Andreas ErnstFounder

Andreas Ernst Germany - ND

Expert in protein engineering with a keen interest in drug development for the treatment of autoimmune diseases.